US Federal 2023-2024 Regular Session

US Federal House Bill HB75

Introduced
1/9/23  
Refer
1/9/23  

Caption

Prescription Freedom Act of 2023 This bill generally eliminates the authority of the Food and Drug Administration (FDA) to require that a drug be dispensed only with a prescription. However, the FDA may continue to require a prescription for any drug intended for terminating a pregnancy.

Impact

The potential impact of HB 75 on state laws would be extensive, moving the minimum regulatory requirement from federal to state levels, thereby introducing a patchwork of regulations that could vary widely across the country. This decentralization could also enhance access to various medications, as it would allow individual states to adopt less restrictive policies concerning the dispensing of drugs. However, critics warn that without federal oversight, there could be negative outcomes regarding the safety and effectiveness of medications prescribed or sold in less regulated environments.

Summary

House Bill 75, known as the Prescription Freedom Act of 2023, seeks to repeal the Food and Drug Administration's (FDA) authority to mandate that certain drugs be dispensed only with a prescription. If passed, the legislation would significantly alter the regulatory landscape concerning medication distribution in the United States, allowing for state laws to govern the dispensing of drugs that were previously under federal prescription rules. Notably, the bill preserves the FDA's authority over drugs intended for terminating pregnancies, thus offering a midpoint between deregulation and existing reproductive health standards.

Contention

The bill has sparked considerable debate among legislators, healthcare professionals, and advocacy groups. Proponents argue that it enhances patient autonomy, empowering individuals to obtain needed medications without the barrier of a prescription. Conversely, opponents highlight the risks associated with unsupervised drug access, including potential misuse and adverse health effects. The discussion is particularly heated regarding the implications for public health and safety, as the absence of federal prescriptions could lead to increased dangers, particularly for vulnerable populations.

Companion Bills

No companion bills found.

Previously Filed As

US HB89

Prescription Freedom Act of 2025This bill generally eliminates the authority of the Food and Drug Administration (FDA) to require that a drug be dispensed only with a prescription. However, the FDA may continue to require a prescription for any drug intended for terminating a pregnancy.

US S07562

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

US A2718

Requires continued coverage of prescription drugs for certain medical conditions.

US LB10

Change requirements relating to wholesale drug distributors and dispensing of certain prescription drugs

US HB2199

Prescription drugs; advertising; requirements

US SB1094

Prescription drugs.

US SB00331

An Act Concerning Step Therapy Requirements For Prescription Drugs Covered Under The Medicaid Program And Required Notice To Enrollees Of Prescription Drug Payment Suspensions, Denials Or Imposition Of New Requirements.

US SB289

Relating to prescription drugs.

US HB126

relative to prescriptions for certain controlled drugs.

US HB126

Relative to prescriptions for certain controlled drugs.

Similar Bills

No similar bills found.